Investigational agents for Crohn's disease

Author： Cottone Mario   Orlando Ambrogio   Renna Sara  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.10, 2010-10, pp. : 1147-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-TNF agents in Crohn’s disease

By Assche G.V.   Rutgeerts P.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 103-111

Informa Healthcare

Access to resources Recommend Favorite

On the Horizon: Promising Investigational Antiretroviral Agents

By  

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1091-1103

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational agents for the irritable bowel syndrome

By Ghaith Ola   El-Halabi Mustapha   Hashash Jana G   Sharara Ala I  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1161-1178

Informa Healthcare

Access to resources Recommend Favorite

Investigational pharmacologic treatment for liver disease

By Siatkosky Lori L   Shermock Kenneth M   Younossi Zobair M  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1281-1293

Informa Healthcare

Access to resources Recommend Favorite

Investigational agents against platinum-resistant ovarian cancer

By Lorusso Domenica   Ferrandina Gabriella   Fanfani Francesco   Gagliardi Maria Lucia   Scambia Giovanni  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 325-336

Informa Healthcare

Access to resources Recommend Favorite